Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

502.12
Delayed Data
As of Jun 27
 -13.79 / -2.67%
Today’s Change
325.35
Today|||52-Week Range
543.55
+36.78%
Year-to-Date
Agios/Celgene's Leukemia Candidate Positive in Phase I/II
Jun 27 / Zacks.com - Paid Partner Content
On Not Talking About the 'Market'; Darth Vader, Meet Amazon: Jim Cramer's Best Blog
Jun 23 / TheStreet.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU
Jun 27 / Zacks.com - Paid Partner Content
How President Trump Has Sent Biotech Stocks Soaring
Jun 23 / TheStreet.com - Paid Partner Content
Amgen Gets Positive CHMP Opinion for Mimpara Label Expansion
Jun 27 / Zacks.com - Paid Partner Content
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Conatus's PSC Candidate Gets Orphan Designation in the U.S.
Jun 27 / Zacks.com - Paid Partner Content
Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock
Jun 23 / Zacks.com - Paid Partner Content
Novartis Cardiovascular Drug Positive, NSCLC Drug Approved
Jun 26 / Zacks.com - Paid Partner Content
Kamada Withdraws Inhaled AAT Marketing Application in EU
Jun 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close515.91
Today’s open517.55
Day’s range500.74 - 529.99
Volume1,447,343
Average volume (3 months)974,567
Market cap$54.8B
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+12.84%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+18.44%
P/E ratio60.7
Price/Sales8.79
Price/Book12.29

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.47-0.85%
VRTXVertex Pharmaceutica...-4.18-3.13%
BAXBaxter International...-0.29-0.48%
ZTSZoetis Inc+0.04+0.06%
Data as of 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$3.13
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts